Abstract
In this study, we have investigated small multitargeted molecules containing 2-aminopyrimidine scaffold that may further act as precursor for developing more potent antibacterials. An efficient route to 2-amino-1,4-dihydropyrimidines by using ultrasound irradiation as the energy source was developed. In silico density functional theory calculations illustrated that tin chloride-mediated Biginelli reaction to produce 2-amino-1,4-dihydropyrimidines has energetics quite accessible under the reaction conditions. Calculated minimum inhibitory concentrations against the various bacterial strains showed that compounds 3 and 11 displayed comparable in vitro activity to ciprofloxacin in Staphylococcus aureus strains and reduced potency in Escherichia coli strains. Further, we investigated in silico ADMET profiling of synthesized compounds in order to understand the mechanism of action that help in explaining in vitro results. Lead compounds 3, 6, and 11 are predicted to have acceptable pharmacokinetic/drug-like properties. Data mining and computational analysis were employed to derive compound promiscuity phenomenon. All the compounds were found nonsubstrate towards various aminergic G-protein coupled receptors, ion-channels, kinase inhibitor, nuclear receptor ligand, protease inhibitor, and enzyme inhibitor. Compound 3 was further investigated by in silico binding to different antibacterial targets. Binding energy data revealed that that these compounds have the ability to bind with other bacterial targets. Hence, combined in silico and in vitro studies shed insights into the mechanism of synthesis and antibacterial activity of 2-amino-1,4-dihydropyrimidines. Results of this study are promising and can be used for further investigation by medicinal chemists to explore their chemical functionalization and in vivo studies.
Similar content being viewed by others
References
Ákos T, Gyorgy MK (2013) Contributions of molecular properties to drug promiscuity. J Med Chem 56:1789–1795
Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648–5652
Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS (1982) Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs 23(6):405–430
Capdeville R, Buchdunger E, Zimmermann J, Matter A (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1:493–502
Cravotto G, Cintas P (2006) Power ultrasound in organic synthesis: moving cavitational chemistry from academia to innovative and large-scale applications. Chem Soc Rev 35:180–196
Drlica K, Malik M, Kerns RJ, Zhao X (2008) Quinolone-mediated bacterial death. Antimicrob Agents Chemother 52:385–392
Egan WJ (2010) Predicting ADME properties in drug discovery. In: Merz KM, Ringe D, and Reynolds CH (eds) Drug design: structure- and ligand-based approaches, Cambridge University Press: New York, USA. pp 165–173.
Frisch MJ, Trucks GW, Schlegel HB et al. (2009) Gaussian 09, Rev. C.01. Gaussian, Inc., Wallingford, CT
Gleeson MP (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 51:817–834
Hansen NT, Irene K, Flemming SJ, Søren B, Svava ÓJ (2006) Prediction of pH-dependent aqueous solubility of druglike molecules. J Chem Inf Model 46:2601–2609
Hariharan PC, Pople JA (1973) Influence of polarization functions on MO hydrogenation energies. Theor Chim Acta 28:213–222
Haupt VJ, Daminelli S, Schroeder M (2013) Drug promiscuity in PDB: protein binding site similarity is key. PLoS ONE 8(6):e65894
Hay PJ, Wadt WR (1985a) Ab initio effective core potentials for molecular calculations. Potentials for the transition metal atoms Sc to Hg. J Chem Phys 82:270
Hay PJ, Wadt WR (1985b) Ab initio effective core potentials for molecular calculations. Potentials for K to Au including the outermost core orbitals. J Chem Phys 82:299
Hebert M (1997) Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Deliv Rev 27:201–214
Ho P-L, Que T-L, Tsang DNC, Ng TK, Chow KH, Seto WH (1999) Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 43:1310–1313
Hutcheson JD, Setola V, Roth BL, Merryman WD (2011) Serotonin receptors and heart valve disease—it was meant 2B. Pharmacol Ther 132:146–157
Johnson SR, Zheng W (2006) Recent progress in the computational prediction of aqueous solubility and absorption. AAPS J 8(1):E27–E40
Kappe CO (1997) A reexamination of the mechanism of the biginelli dihydropyrimidine synthesis. Support for an N-acyliminium ion intermediate. J Org Chem 62(1997):7201–7204
Lagoja IM (2005) Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers 2:1–50
Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785–789
Marvin 15.4.6 (2015) ChemAxon. www.chemaxon.com.
Mason TJ, Lorimer J (2002) Applied sonochemistry: uses of power ultrasound in chemistry and processing. Wiley-VCH, Weinheim
McFarland JW, Berger CM, Froshauer SA, Hayashi SF, Hecker SJ, Jaynes BH, Jefson MR, Kamicker BJ, Lipinski CA, Lundy KM, Reese CP, Vu CB (1997) Quantitative structure−activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida. J Med Chem 40(9):1340–1346
Molecular Operating Environment (MOE), 2012.10; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2016.
Norinder U, Bergström CA (2006) Prediction of ADMET properties. Chem Med Chem 1:920–937
Pacifici G, Nottoli R (1995) Placental transfer of drugs administered to the mother. Clin Pharmacokinetics 28:235–269
Pearlstein R, Vaz R, Rampe D (2003) Understanding the structure activity relationship of the human ether-a-go-go-related gene cardiac K+ channel: a model for bad behavior. J Med Chem 46(11):2017–2022
Peters J-U, Hert J, Bissantz C, Hillebrecht A, Gerebtzoff G, Bendels S, Tillier F, Migeon J, Fischer H, Guba W, Kansy M (2012) Can we discover pharmacological promiscuity early in the drug discovery process? Drug Disc Today 17(7–8):325–335
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612
Proudfoot JR (2005) The evolution of synthetic oral drug properties. Bioorg Med Chem Lett 15:1087–1090
Qiu X, Janson CA, Smith WW, Head M, Lonsdale J, Konstantinidis AK (2001) Refined structures of beta-ketoacyl-acyl carrier protein synthase III. J Mol Biol 307(1):341–356
Rashid U, Batool I, Wadood A, Khan A, Ul-Haq Z, Chaudhary MI, Ansari FL (2013) Structure based virtual screening-driven identification of monastrol as a potent urease inhibitor. J Mol Graphics Modell 43:47–57
Rashid U, Hassan SF, Nazir S, Wadood A, Waseem M, Ansari FL (2015) Synthesis, docking studies, and in silico ADMET predictions of some new derivatives of pyrimidine as potential KSP inhibitors. Med Chem Res 24(1):304–315
Reynolds F, Knott C (1989) Pharmacokinetics in pregnancy and placental drug transfer. Oxf Rev Reprod Biol 11:389–449
Ruan B, Bovee ML, Sacher M, Stathopoulos C, Poralla K, Francklyn CS, Söll DJ (2005) A unique hydrophobic cluster near the active site contributes to differences in borrelidin inhibition among threonyl-tRNA synthetases. Biol Chem 280:571–577
Smith DA (1997) Physicochemical properties in drug metabolism and pharmacokinetics. In: van de Waterbeemd H, Testa B, and Folkers G (eds) Computer-assisted lead finding and optimization: Current tools for medicinal chemistry, Wiley-VCH: Weinheim, Germany. p 267
Smith DA, Jones BC, Walker DK (1996) Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics. Med Res Rev 16:243–266
Stephen PE, Lynn LS (2013) Multitarget ligands in antibacterial research: progress and opportunities. Expert Opin Drug Disc 8:143–156
Stopher DA, Beresford AP, Macrae PV, Humphrey MJ (1988) The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol 12:S55–S59
Sweet F, Fissekis JD (1973) Synthesis of 3,4-dihydro-2(1H)-pyrimidinones and the mechanism of the Biginelli reaction. J Am Chem Soc 95:8741–8749
Waring MJ (2009) Defining optimum lipophilicity and molecular weight ranges for drug candidates—molecular weight dependent lower log D limits based on permeability. Bioorg Med Chem 19:2844–2851
Watanabe M, Koike H, Ishiba T, Okada T, Seo S, Hirai K (1997) Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Bioorg Med Chem 5:437–444
Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192–204
Waterbeemd H, Smith DA, Jones BC (2001) Lipophilicity in PK design: methyl, ethyl, futile. J Comput Aided Mol Design 15:273–286
Williams RT (1978) Species variations in the pathways of drug metabolism. Environ Health Perspect 22:133–138
Yang Y, Engkvist O, Llinàs A, Chen H (2012) Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds. J Med Chem 55:3667–3677
Yogev R, Kolling WM, Williams T (1981) Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis. Pediatrics 67:656–660
Acknowledgments
The Higher Education Commission (HEC), Pakistan is thankfully acknowledged for providing financial support to Umer Rashid for startup grant under IPFP program (HEC No: PM-IPFP/HRD/HEC/2011/346).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interest
The author declares that they have no competing interests.
Electronic Supplementary material
Rights and permissions
About this article
Cite this article
Ahmad, M.J., Hassan, S.F., Nisa, R.U. et al. Synthesis, in vitro potential and computational studies on 2-amino-1, 4-dihydropyrimidines as multitarget antibacterial ligands. Med Chem Res 25, 1877–1894 (2016). https://doi.org/10.1007/s00044-016-1613-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-016-1613-z